regeneron dna - Search News

News

Regeneron buying 23andMe

USA TODAY · 14h

Regeneron buying 23andMe; What happened to 23andMe? Should I delete 23andMe data?

Regeneron Pharmaceuticals said it will acquire 23andMe's business. What happened to 23andMe? Should you delete your data? What to know.

Mashable on MSN · 1d

Now we know who's getting 23andMe's DNA data. Meet Regeneron Pharmaceuticals.

But, more concerning than the success or failure of a particular company, was this question: What would happen to 23andMe's vast trove of highly personal customer data? We aren't just talking about usernames and birthdays.

CNN on MSN · 1d

Regeneron to buy bankrupt DNA testing firm 23andMe for $256 million

Drugmaker Regeneron Pharmaceuticals will buy genetic testing firm 23andMe for $256 million through a bankruptcy auction, the companies said Monday.

58m

Regeneron's 23andMe Steal: Smart Genetics Play That Won't Cure Near-Term Growth Pains

Regeneron's third-largest drug, Libtayo, remains the standard of care in advanced cutaneous squamous cell carcinoma. However, ...

1don MSN

Regeneron agrees to buy bankrupt 23andMe, promises ethical use of customers' DNA data

Regeneron Pharmaceuticals said on Monday it will buy genetic testing firm 23andMe Holding for $256 million through a ...

1don MSN

23andMe sells its most valuable asset to biotech company Regeneron, which promises to keep your DNA private

Regeneron said it will continue uninterrupted service of 23andMe’s consumer genome services after its purchase closes as ...

1d

23andMe was once worth $6 billion. What's left of the DNA testing startup is being bought for $256 million.

Regeneron is buying the assets of 23andMe, which filed for Chapter 11 bankruptcy in March after facing a series of hurdles ...

Stocktwits on MSN1d

Regeneron To Buy Assets Of 23andMe For $256M: Retail Says ‘Fantastic’ For Future R&D Efforts

Drugmaker Regeneron Pharmaceuticals, Inc. (REGN) said on Monday that it will acquire the assets of bankrupt biotechnology ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results